108 related articles for article (PubMed ID: 8092258)
1. Effects of ANG II, ETA, and TxA2 receptor antagonists on cyclosporin A renal vasoconstriction.
Conger JD; Kim GE; Robinette JB
Am J Physiol; 1994 Sep; 267(3 Pt 2):F443-9. PubMed ID: 8092258
[TBL] [Abstract][Full Text] [Related]
2. Sequential agonist activation and site-specific mediation of acute cyclosporine constriction in rat renal arterioles.
Lanese DM; Falk SA; Conger JD
Transplantation; 1994 Dec; 58(12):1371-8. PubMed ID: 7809931
[TBL] [Abstract][Full Text] [Related]
3. Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
Barrett RJ; Droppleman DA
Am J Physiol; 1993 Nov; 265(5 Pt 2):F651-9. PubMed ID: 8238545
[TBL] [Abstract][Full Text] [Related]
4. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.
Lanese DM; Conger JD
J Clin Invest; 1993 May; 91(5):2144-9. PubMed ID: 8486781
[TBL] [Abstract][Full Text] [Related]
5. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats.
Matsuura T; Miura K; Ebara T; Yukimura T; Yamanaka S; Kim S; Iwao H
Br J Pharmacol; 1997 Sep; 122(1):81-6. PubMed ID: 9298531
[TBL] [Abstract][Full Text] [Related]
6. Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production.
Vågnes ØB; Iversen BM; Arendshorst WJ
Am J Physiol Renal Physiol; 2007 Sep; 293(3):F860-7. PubMed ID: 17567934
[TBL] [Abstract][Full Text] [Related]
7. Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: Role of arterial baroreflexes and vasoreactivity.
Nasser SA; Sabra R; Elmallah AI; El-Din MM; Khedr MM; El-Mas MM
Life Sci; 2016 Oct; 163():1-10. PubMed ID: 27575704
[TBL] [Abstract][Full Text] [Related]
8. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Muller C; Endlich K; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
[TBL] [Abstract][Full Text] [Related]
9. Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats.
Thompson A; Valeri CR; Lieberthal W
Am J Physiol; 1995 Aug; 269(2 Pt 2):H743-8. PubMed ID: 7653640
[TBL] [Abstract][Full Text] [Related]
10. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition.
Qiu C; Baylis C
Kidney Int; 1999 Jun; 55(6):2390-6. PubMed ID: 10354287
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of vasoconstriction induced by chronic inhibition of nitric oxide in rats.
Bank N; Aynedjian HS; Khan GA
Hypertension; 1994 Sep; 24(3):322-8. PubMed ID: 8082939
[TBL] [Abstract][Full Text] [Related]
12. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
13. Role of nitric oxide in long-term angiotensin II-induced renal vasoconstriction.
Manning RD; Hu L; Mizelle HL; Granger JP
Hypertension; 1993 Jun; 21(6 Pt 2):949-55. PubMed ID: 8505105
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin gene-related peptide reduces renal vascular resistance and modulates ET-1-induced vasoconstriction.
Amuchastegui CS; Remuzzi G; Perico N
Am J Physiol; 1994 Nov; 267(5 Pt 2):F839-44. PubMed ID: 7977788
[TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity.
Bobadilla NA; Tapia E; Franco M; López P; Mendoza S; García-Torres R; Alvarado JA; Herrera-Acosta J
Kidney Int; 1994 Sep; 46(3):773-9. PubMed ID: 7996799
[TBL] [Abstract][Full Text] [Related]
16. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
Kramer HJ; Horacek V; Bäcker A; Vaneckova I; Heller J
Kidney Blood Press Res; 2004; 27(1):10-7. PubMed ID: 14583658
[TBL] [Abstract][Full Text] [Related]
17. Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension.
Cediel E; Vázquez-Cruz B; Navarro-Cid J; de las Heras N; Sanz-Rosa D; Cachofeiro V; Lahera V
Kidney Int Suppl; 2002 Dec; (82):S2-7. PubMed ID: 12410847
[TBL] [Abstract][Full Text] [Related]
18. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II.
Cediel E; de Las Heras N; Sanz-Rosa D; Velasco O; Cachofeiro V; Lahera V
Kidney Int Suppl; 2005 Jan; (93):S3-9. PubMed ID: 15613065
[TBL] [Abstract][Full Text] [Related]
19. An experimental study of altered nitric oxide metabolism as a mechanism of cyclosporin-induced renal vasoconstriction.
Bloom IT; Bentley FR; Spain DA; Garrison RN
Br J Surg; 1995 Feb; 82(2):195-8. PubMed ID: 7749687
[TBL] [Abstract][Full Text] [Related]
20. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats.
Danielson LA; Conrad KP
J Clin Invest; 1995 Jul; 96(1):482-90. PubMed ID: 7542284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]